Kuangli Bio-Tech Holdings Co., Ltd. (6431.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.51B
Enterprise Value2.79B
P/E Ratio-9.08
PEG Ratio-0.56
Price/Sales Ratio5.03
Price/Book Ratio3.21
Enterprise/Revenue5.64
Enterprise/EBITDA-23.56

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.55
Operating Margin-0.44
AD

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.33

Income Statement

Revenue377.03M
Revenue/Share3.63
Gross Profit70.41M
EBITDA-92.46M
Net Income-193.04M
Diluted EPS-2.07

Balance Sheet

Total Cash290.63M
Total Cash/Share2.98
Total Debt505.34M
Total Debt/Equity0.91
Current Ratio1.22
Book Value Per Share5.72

Price History

52-Week Change6.73
52-Week High32
52-Week Low14.85
Moving Average 50 Days20.02
Moving Average 200 Days21.84

Statistics

Average Volume171,627
Shares Outstanding97.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD